{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T20:37:55Z","timestamp":1764794275507,"version":"build-2065373602"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T00:00:00Z","timestamp":1655251200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.ajoc.2022.101627","type":"journal-article","created":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T14:08:13Z","timestamp":1655388493000},"page":"101627","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Plasmapheresis as a viable treatment option for scleritis"],"prefix":"10.1016","volume":"27","author":[{"given":"Janine M.","family":"Preble","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xihui","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ajoc.2022.101627_bib1","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/APO.0000000000000341","article-title":"Current approach for the diagnosis and management of noninfective scleritis","volume":"10","author":"Dutta Majumder","year":"2021","journal-title":"Asia-Pacific Journal of Ophthalmology"},{"key":"10.1016\/j.ajoc.2022.101627_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.108078","article-title":"Current insights in the pathogenesis of scleritis","volume":"197","author":"Vergouwen","year":"2020","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.ajoc.2022.101627_bib3","doi-asserted-by":"crossref","DOI":"10.1007\/s40123-021-00393-8","article-title":"Biologic therapies and small molecules for the management of non-infectious scleritis: a narrative review","author":"Sota","year":"2021","journal-title":"Ophthalmol Ther"},{"issue":"5","key":"10.1016\/j.ajoc.2022.101627_bib4","first-page":"228","article-title":"Peripheral corneal ulcer associated with benign hypergammaglobulinemic purpura","volume":"23","author":"Climenhaga","year":"1988","journal-title":"Can J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajoc.2022.101627_bib5","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2019-232379","article-title":"Treatment of recalcitrant orbital inflammatory syndrome with plasmapheresis therapy","volume":"13","author":"Rodriguez Torres","year":"2020","journal-title":"BMJ Case Rep"},{"issue":"3","key":"10.1016\/j.ajoc.2022.101627_bib6","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s10047-018-1044-3","article-title":"Immunoadsorption plasmapheresis treatment for the recurrent exacerbation of neuromyelitis optica spectrum disorder with a fluctuating anti-aquaporin-4 antibody level","volume":"21","author":"Nishimura","year":"2018","journal-title":"J Artif Organs"},{"key":"10.1016\/j.ajoc.2022.101627_bib7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.15761\/GVI.1000108","article-title":"Plasmapheresis therapy for immune-mediated diseases in neurology: literature review","volume":"1","author":"Meneses de Oliveira","year":"2016","journal-title":"Glob Vaccines Immunol"},{"issue":"2","key":"10.1016\/j.ajoc.2022.101627_bib8","first-page":"167","article-title":"Xanthoma-like skin changes in an elderly woman with a normal lipid profile","volume":"25","author":"Nockowski","year":"2017","journal-title":"Acta Dermatovenerol Croat"},{"issue":"2","key":"10.1016\/j.ajoc.2022.101627_bib9","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4274\/tjo.80688","article-title":"Thyroid-associated ophthalmopathy","volume":"47","author":"\u015eahl\u0131","year":"2017","journal-title":"Turk J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajoc.2022.101627_bib10","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0248-8663(83)80021-6","article-title":"L'utilisation des \u00e9changes plasmatiques dans le traitement de la maladie de Beh\u00e7et. Etude pr\u00e9liminaire \u00e0 propos de 7 observations [Plasma exchange in the treatment of Behcet's disease. Preliminary study apropos of 7 cases]","volume":"4","author":"You","year":"1983","journal-title":"Rev Med Interne"},{"issue":"4","key":"10.1016\/j.ajoc.2022.101627_bib11","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0161-6420(88)33155-6","article-title":"Plasmapheresis treatment in patients with severe atopic keratoconjunctivitis","volume":"95","author":"Aswad","year":"1988","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ajoc.2022.101627_bib12","first-page":"439","article-title":"Bilateral diffuse uveal melanocytic proliferation: case report and literature review. Acta","volume":"95","author":"Klemp","year":"2017","journal-title":"Ophthalmol Times"},{"issue":"6","key":"10.1016\/j.ajoc.2022.101627_bib13","doi-asserted-by":"crossref","first-page":"658","DOI":"10.5301\/ejo.5000923","article-title":"Plasmapheresis, intravenous immunoglobulins, and autologous serum eyedrops in the acute eye complications of toxic epidermal necrolysis","volume":"27","author":"Pinna","year":"2017","journal-title":"Eur J Ophthalmol"},{"issue":"11","key":"10.1016\/j.ajoc.2022.101627_bib14","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1001\/archopht.124.11.1654","article-title":"Plasmapheresis for lupus retinal vasculitis","volume":"124","author":"Papadaki","year":"2006","journal-title":"Arch Ophthalmol"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993622003735?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993622003735?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:01:01Z","timestamp":1762527661000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451993622003735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":14,"alternative-id":["S2451993622003735"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2022.101627","relation":{},"ISSN":["2451-9936"],"issn-type":[{"type":"print","value":"2451-9936"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasmapheresis as a viable treatment option for scleritis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2022.101627","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101627"}}